Antibiotic properties of nanoparticles

Last updated

Nanoparticles have been studied extensively for their antimicrobial properties in order to fight super bug bacteria. Several characteristics in particular make nanoparticles strong candidates as a traditional antibiotic drug alternative. Firstly, they have a high surface area to volume ratio, which increases contact area with target organisms. [1] [2] Secondly, they may be synthesized from polymers, lipids, and metals. [1] Thirdly, a multitude of chemical structures, such as fullerenes and metal oxides, allow for a diverse set of chemical functionalities.

Contents

The key to nanoparticle efficacy against antibiotic resistant strains of bacteria lies in their small size. On the nano scale, particles can behave as molecules when interacting with a cell which allows them to easily penetrate the cell membrane and interfere in vital molecular pathways if the chemistry is possible. [3] While their antibiotic properties against certain pathogens are important, oral antibiotics packaged in lipid nanoparticles can reduce collateral damage on the gut microbiota. [4]

Metal Nanoparticles

A strong research focus has been placed on triggering production of excessive reactive oxygen species (ROS) using nanoparticles injected into bacterial cells. The presence of excessive ROS can stress the cell structure leading to damaged DNA/RNA, decreased membrane activity, disrupted metabolic activity, and harmful side reactions generating chemicals such as peroxides. [5] [6] ROS production has been induced generally through the introduction of both metal oxide and positively charged metal nanoparticles in the cell, such as iron oxides and silver. The positive charge of the metal is attracted to the negative charge of the cell membrane which it then easily penetrates. Redox reactions take place in the cell between the metals and oxygen containing species in the cell to produce ROS. [7] Other novel techniques include utilizing quantum dots such as cadmium telluride, under a bright light source to excite and release electrons; this process initializes ROS production similar to the metal nanoparticles. [5]

Carbon Structures

Carbon nanostructures such as graphene oxide (GO) sheets, nano tubes, and fullerenes have proven antimicrobial properties when used synergistically with other methods. UV radiation directed at GO sheets, for example, disrupts bacterial cell activity and colony growth via ROS production. Doping nano tubes or fullerenes with silver or copper nanoparticles may also harm the cells ability to grow and replicate DNA. [8] Nano tubes and fullerenes in particular are being studied as aqueous dispersions rather than polymers, metals or other traditional dry solid particulates. The exact mechanism which promotes this synergy is not clearly understood but it is believed to be linked to the unique surface chemistry of carbon nanostructures (i.e. the large aspect ratio of carbon nanotubes, high surface energy in GO sheets). Human applications of carbon nano materials have not been tested due to the unknown potential hazards. Current research on the carcinogenic effects, if any, of carbon nanostructures is still in its infancy and there is therefore no clear consensus on the topic. [9]

Drug Synergies

Nanoparticles can enhance the effects of traditional antibiotics which a bacterium may have become resistant to, and decrease the overall minimum inhibitory concentration (MIC) required for a drug. Silver nanoparticles improve the activity of amoxicillin, penicillin, and gentamicin in bacteria by altering membrane permeability and improving drug delivery. [10] [11] nanoparticles themselves may have antimicrobial properties enhanced or induced with the addition of organic drugs. Gold particles, while not inherently antimicrobial, were discovered to express antimicrobial properties when functionalized with ampicillin. [12] In addition to this, gold nanoparticles demonstrated improved membrane permeability with the addition of 4,6-diamino-2-pyrimidenthiol (DAPT) and non-antibiotic amines (NAA) to their surfaces. [13]

Related Research Articles

<span class="mw-page-title-main">Antimicrobial resistance</span> Resistance of microbes to drugs directed against them

Antimicrobial resistance occurs when microbes evolve mechanisms that protect them from antimicrobials, which are drugs used to treat infections. This resistance affects all classes of microbes, including bacteria, viruses, protozoa, and fungi. Together, these adaptations fall under the AMR umbrella, posing significant challenges to healthcare worldwide. Misuse and improper management of antimicrobials are primary drivers of this resistance, though it can also occur naturally through genetic mutations and the spread of resistant genes.

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.

<span class="mw-page-title-main">Polymyxin</span> Group of antibiotics

Polymyxins are antibiotics. Polymyxins B and E are used in the treatment of Gram-negative bacterial infections. They work mostly by breaking up the bacterial cell membrane. They are part of a broader class of molecules called nonribosomal peptides.

<span class="mw-page-title-main">Nanomaterials</span> Materials whose granular size lies between 1 and 100 nm

Nanomaterials describe, in principle, chemical substances or materials of which a single unit is sized between 1 and 100 nm.

An antimicrobial is an agent that kills microorganisms (microbicide) or stops their growth. Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. For example, antibiotics are used against bacteria, and antifungals are used against fungi. They can also be classified according to their function. The use of antimicrobial medicines to treat infection is known as antimicrobial chemotherapy, while the use of antimicrobial medicines to prevent infection is known as antimicrobial prophylaxis.

<span class="mw-page-title-main">Nanochemistry</span> Combination of chemistry and nanoscience

Nanochemistry is an emerging sub-discipline of the chemical and material sciences that deals with the development of new methods for creating nanoscale materials. The term "nanochemistry" was first used by Ozin in 1992 as 'the uses of chemical synthesis to reproducibly afford nanomaterials from the atom "up", contrary to the nanoengineering and nanophysics approach that operates from the bulk "down"'. Nanochemistry focuses on solid-state chemistry that emphasizes synthesis of building blocks that are dependent on size, surface, shape, and defect properties, rather than the actual production of matter. Atomic and molecular properties mainly deal with the degrees of freedom of atoms in the periodic table. However, nanochemistry introduced other degrees of freedom that controls material's behaviors by transformation into solutions. Nanoscale objects exhibit novel material properties, largely as a consequence of their finite small size. Several chemical modifications on nanometer-scaled structures approve size dependent effects.

<span class="mw-page-title-main">Efflux pump</span> Protein complexes that move compounds, generally toxic, out of bacterial cells

An efflux pump is an active transporter in cells that moves out unwanted material. Efflux pumps are an important component in bacteria in their ability to remove antibiotics. The efflux could also be the movement of heavy metals, organic pollutants, plant-produced compounds, quorum sensing signals, bacterial metabolites and neurotransmitters. All microorganisms, with a few exceptions, have highly conserved DNA sequences in their genome that encode efflux pumps. Efflux pumps actively move substances out of a microorganism, in a process known as active efflux, which is a vital part of xenobiotic metabolism. This active efflux mechanism is responsible for various types of resistance to bacterial pathogens within bacterial species - the most concerning being antibiotic resistance because microorganisms can have adapted efflux pumps to divert toxins out of the cytoplasm and into extracellular media.

<span class="mw-page-title-main">Nanocomposite</span> Solid material with nano-scale structure

Nanocomposite is a multiphase solid material where one of the phases has one, two or three dimensions of less than 100 nanometers (nm) or structures having nano-scale repeat distances between the different phases that make up the material.

Nanotoxicology is the study of the toxicity of nanomaterials. Because of quantum size effects and large surface area to volume ratio, nanomaterials have unique properties compared with their larger counterparts that affect their toxicity. Of the possible hazards, inhalation exposure appears to present the most concern, with animal studies showing pulmonary effects such as inflammation, fibrosis, and carcinogenicity for some nanomaterials. Skin contact and ingestion exposure are also a concern.

A lipopeptide is a molecule consisting of a lipid connected to a peptide. They are able to self-assemble into different structures. Many bacteria produce these molecules as a part of their metabolism, especially those of the genus Bacillus, Pseudomonas and Streptomyces. Certain lipopeptides are used as antibiotics. Due to the structural and molecular properties such as the fatty acid chain, it poses the effect of weakening the cell function or destroying the cell. Other lipopeptides are toll-like receptor agonists. Certain lipopeptides can have strong antifungal and hemolytic activities. It has been demonstrated that their activity is generally linked to interactions with the plasma membrane, and sterol components of the plasma membrane could play a major role in this interaction. It is a general trend that adding a lipid group of a certain length to a lipopeptide will increase its bactericidal activity. Lipopeptides with a higher amount of carbon atoms, for example 14 or 16, in its lipid tail will typically have antibacterial activity as well as anti-fungal activity. Therefore, an increase in the alkyl chain can make lipopeptides soluble in water. As well, it opens the cell membrane of the bacteria, so antimicrobial activity can take place.

Green nanotechnology refers to the use of nanotechnology to enhance the environmental sustainability of processes producing negative externalities. It also refers to the use of the products of nanotechnology to enhance sustainability. It includes making green nano-products and using nano-products in support of sustainability.

Magnetic nanoparticles (MNPs) are a class of nanoparticle that can be manipulated using magnetic fields. Such particles commonly consist of two components, a magnetic material, often iron, nickel and cobalt, and a chemical component that has functionality. While nanoparticles are smaller than 1 micrometer in diameter, the larger microbeads are 0.5–500 micrometer in diameter. Magnetic nanoparticle clusters that are composed of a number of individual magnetic nanoparticles are known as magnetic nanobeads with a diameter of 50–200 nanometers. Magnetic nanoparticle clusters are a basis for their further magnetic assembly into magnetic nanochains. The magnetic nanoparticles have been the focus of much research recently because they possess attractive properties which could see potential use in catalysis including nanomaterial-based catalysts, biomedicine and tissue specific targeting, magnetically tunable colloidal photonic crystals, microfluidics, magnetic resonance imaging, magnetic particle imaging, data storage, environmental remediation, nanofluids, optical filters, defect sensor, magnetic cooling and cation sensors.

<span class="mw-page-title-main">Platinum nanoparticle</span>

Platinum nanoparticles are usually in the form of a suspension or colloid of nanoparticles of platinum in a fluid, usually water. A colloid is technically defined as a stable dispersion of particles in a fluid medium.

<span class="mw-page-title-main">Silver nanoparticle</span> Ultrafine particles of silver between 1 nm and 100 nm in size

Silver nanoparticles are nanoparticles of silver of between 1 nm and 100 nm in size. While frequently described as being 'silver' some are composed of a large percentage of silver oxide due to their large ratio of surface to bulk silver atoms. Numerous shapes of nanoparticles can be constructed depending on the application at hand. Commonly used silver nanoparticles are spherical, but diamond, octagonal, and thin sheets are also common.

Polymers with the ability to kill or inhibit the growth of microorganisms such as bacteria, fungi, or viruses are classified as antimicrobial agents. This class of polymers consists of natural polymers with inherent antimicrobial activity and polymers modified to exhibit antimicrobial activity. Polymers are generally nonvolatile, chemically stable, and can be chemically and physically modified to display desired characteristics and antimicrobial activity. Antimicrobial polymers are a prime candidate for use in the food industry to prevent bacterial contamination and in water sanitation to inhibit the growth of microorganisms in drinking water.

An antimicrobial surface is coated by an antimicrobial agent that inhibits the ability of microorganisms to grow on the surface of a material. Such surfaces are becoming more widely investigated for possible use in various settings including clinics, industry, and even the home. The most common and most important use of antimicrobial coatings has been in the healthcare setting for sterilization of medical devices to prevent hospital-associated infections, which have accounted for almost 100,000 deaths in the United States. In addition to medical devices, linens and clothing can provide a suitable environment for many bacteria, fungi, and viruses to grow when in contact with the human body which allows for the transmission of infectious disease.

Antibiotic synergy is one of three responses possible when two or more antibiotics are used simultaneously to treat an infection. In the synergistic response, the applied antibiotics work together to produce an effect more potent than if each antibiotic were applied singly. Compare to the additive effect, where the potency of an antibiotic combination is roughly equal to the combined potencies of each antibiotic singly, and antagonistic effect, where the potency of the combination is less than the combined potencies of each antibiotic.

A proteolipid is a protein covalently linked to lipid molecules, which can be fatty acids, isoprenoids or sterols. The process of such a linkage is known as protein lipidation, and falls into the wider category of acylation and post-translational modification. Proteolipids are abundant in brain tissue, and are also present in many other animal and plant tissues. They include ghrelin, a peptide hormone associated with feeding. Many proteolipids have bound fatty acid chains, which often provide an interface for interacting with biological membranes and act as lipidons that direct proteins to specific zones.

Chelated platinum is an ionized form of platinum that forms two or more bonds with a counter ion. Some platinum chelates are claimed to have antimicrobial activity.

Nanoneuroscience is an interdisciplinary field that integrates nanotechnology and neuroscience. One of its main goals is to gain a detailed understanding of how the nervous system operates and, thus, how neurons organize themselves in the brain. Consequently, creating drugs and devices that are able to cross the blood brain barrier (BBB) are essential to allow for detailed imaging and diagnoses. The blood brain barrier functions as a highly specialized semipermeable membrane surrounding the brain, preventing harmful molecules that may be dissolved in the circulation blood from entering the central nervous system.

References

  1. 1 2 Kandi, Venkataramana; Kandi, Sabitha (2015-04-17). "Antimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance". Epidemiology and Health. 37: e2015020. doi:10.4178/epih/e2015020. ISSN   2092-7193. PMC   4459197 . PMID   25968114.
  2. Hajipour, Mohammad J.; Fromm, Katharina M.; Akbar Ashkarran, Ali; Jimenez de Aberasturi, Dorleta; Larramendi, Idoia Ruiz de; Rojo, Teofilo; Serpooshan, Vahid; Parak, Wolfgang J.; Mahmoudi, Morteza (2012-10-01). "Antibacterial properties of nanoparticles" (PDF). Trends in Biotechnology. 30 (10): 499–511. doi:10.1016/j.tibtech.2012.06.004. PMID   22884769. S2CID   32908643.
  3. Allahverdiyev, Adil M.; Kon, Kateryna Volodymyrivna; Abamor, Emrah Sefik; Bagirova, Malahat; Rafailovich, Miriam (2011-11-01). "Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents". Expert Review of Anti-Infective Therapy. 9 (11): 1035–1052. doi:10.1586/eri.11.121. PMID   22029522. S2CID   24287211.
  4. He, Xiguo; Karlsson, Philip A.; Xiong, Ruisheng; Moodie, Lindon W. K.; Wang, Helen; Bergström, Christel A. S.; Hubert, Madlen (2025-01-15). "Liquid crystal nanoparticles for oral combination antibiotic therapies: A strategy towards protecting commensal gut bacteria during treatment". Journal of Colloid and Interface Science. 678: 287–300. doi:10.1016/j.jcis.2024.08.230. ISSN   0021-9797.
  5. 1 2 Bennington-Castro, Joseph (2016-03-01). "Bio Focus: Light-activated quantum dots kill antibiotic-resistant superbugs". MRS Bulletin. 41 (3): 178–179. Bibcode:2016MRSBu..41..178B. doi: 10.1557/mrs.2016.35 . ISSN   0883-7694.
  6. Huh, Ae Jung; Kwon, Young Jik (2011-12-10). ""Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era". Journal of Controlled Release. 156 (2): 128–145. doi:10.1016/j.jconrel.2011.07.002. ISSN   1873-4995. PMID   21763369.
  7. Cheng, Guyue; Dai, Menghong; Ahmed, Saeed; Hao, Haihong; Wang, Xu; Yuan, Zonghui (2016-04-08). "Antimicrobial Drugs in Fighting against Antimicrobial Resistance". Frontiers in Microbiology. 7: 470. doi: 10.3389/fmicb.2016.00470 . PMC   4824775 . PMID   27092125.
  8. Tegou, Evangelia; Magana, Maria; Katsogridaki, Alexandra Eleni; Ioannidis, Anastasios; Raptis, Vasilios; Jordan, Sheldon; Chatzipanagiotou, Stylianos; Chatzandroulis, Stavros; Ornelas, Catia (2016-05-01). "Terms of endearment: Bacteria meet graphene nanosurfaces". Biomaterials. 89: 38–55. doi:10.1016/j.biomaterials.2016.02.030. PMID   26946404.
  9. Rittinghausen, Susanne; Hackbarth, Anja; Creutzenberg, Otto; Ernst, Heinrich; Heinrich, Uwe; Leonhardt, Albrecht; Schaudien, Dirk (2014-11-20). "The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats". Particle and Fibre Toxicology. 11: 59. doi: 10.1186/s12989-014-0059-z . PMC   4243371 . PMID   25410479.
  10. Flórez-Castillo, J.M., Ropero-Vega, J.L., Perullini, M., Jobbágy, M. Biopolymeric pellets of polyvinyl alcohol and alginate for the encapsulation of Ib-M6 peptide and its antimicrobial activity against E. coli (2019) Heliyon, 5 (6), art. no. e01872. DOI: 10.1016/j.heliyon.2019.e01872 Flórez-Castillo, J.M.; Ropero-Vega, J.L.; Perullini, Mercedes; Jobbágy, Matias (2019). "Biopolymeric pellets of polyvinyl alcohol and alginate for the encapsulation of Ib-M6 peptide and its antimicrobial activity against E. coli". Heliyon. 5 (6): e01872. Bibcode:2019Heliy...501872F. doi: 10.1016/j.heliyon.2019.e01872 . hdl: 11336/123693 . PMC   6551476 . PMID   31194071.
  11. Smekalova, Monika; Aragon, Virginia; Panacek, Ales; Prucek, Robert; Zboril, Radek; Kvitek, Libor (2016-03-01). "Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens". Veterinary Journal. 209: 174–179. doi:10.1016/j.tvjl.2015.10.032. PMID   26832810.
  12. Brown, Ashley N.; Smith, Kathryn; Samuels, Tova A.; Lu, Jiangrui; Obare, Sherine O.; Scott, Maria E. (2012-04-15). "Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus". Applied and Environmental Microbiology. 78 (8): 2768–2774. Bibcode:2012ApEnM..78.2768B. doi:10.1128/AEM.06513-11. PMC   3318834 . PMID   22286985.
  13. Zhao, Yuyun; Chen, Zeliang; Chen, Yanfen; Xu, Jie; Li, Jinghong; Jiang, Xingyu (2013-09-04). "Synergy of Non-antibiotic Drugs and Pyrimidinethiol on Gold Nanoparticles against Superbugs". Journal of the American Chemical Society. 135 (35): 12940–12943. doi:10.1021/ja4058635. PMID   23957534.